5 Biotech Stocks To Check Out Before The End Of 2021 With the coronavirus pandemic kicking back into full swing, biotech stocks are once again… Read More »5 Biotech Stocks For Your Late December 2021 Watchlist
With this aerospace stock trading more like a biotech stock, investors may want to consider throwing out the traditional rules for trading aerospace stocks and… Read More »An Aerospace Stock That’s Trading More Like A Biotech Stock
While this biotech’s CEO lives a frugal personal life, he is planning a huge ramp-up in the company’s spending – an investment that could help… Read More »A Huge Ramp-Up In Spending Could Help This Biotech “Win The War On Cancer”
With the pandemic still raging around the world and other infectious diseases in need of better tools to fight them – not to mention the… Read More »2 Vaccine Makers To Consider Injecting Into Your Portfolio This Summer
What impact would waiving patent protections for COVID-19 vaccines – a move the Biden administration has expressed support for – have on biotech stocks? Potentially… Read More »Biotech Profits & The COVID Vaccine Patent Battle
With the recent pullback in biotech stocks having created some attractive entry points, here are three “big-time” biotech stocks worth considering right now. CLICK HERE.
Looking for biotech trade ideas? Reflecting “a hat trick of perfect patterns in biotech stocks,” here are three stocks (or, more accurately, one stock and… Read More »A Biotech Hat Trick
While COVID-19 vaccines are grabbing the bulk of the attention, biotech breakthroughs are also being made when it comes to cancer, genetic diseases, neurodegenerative disorders… Read More »7 Biotech Breakthrough Plays (Beyond COVID Vaccines)
Biotech stocks are all the rage right now – and within the biotech sector, deals are all the rage. Here’s a look at recent investments,… Read More »Biotech Wheeling And Dealing
With the first FDA-approved drug for weight management in people with rare genetic disorders of obesity – its first new drug approval – shares of… Read More »FDA Approval Of Its Obesity Drug Has This Small Biotech Rocketing Up